Advanced search
1 file | 62.45 KB

NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls—Comment on Russell‐Goldman et al

David Creytens (UGent)
Author
Organization
Keywords
Cancer Research, Oncology

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 62.45 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Creytens, David. 2019. “NKX2.2 Immunohistochemistry in the Distinction of Ewing Sarcoma from Cytomorphologic Mimics: Diagnostic Utility and pitfalls—Comment on Russell‐Goldman Et Al.” Cancer Cytopathology.
APA
Creytens, D. (2019). NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls—Comment on Russell‐Goldman et al. Cancer Cytopathology.
Vancouver
1.
Creytens D. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls—Comment on Russell‐Goldman et al. Cancer Cytopathology. Wiley; 2019;
MLA
Creytens, David. “NKX2.2 Immunohistochemistry in the Distinction of Ewing Sarcoma from Cytomorphologic Mimics: Diagnostic Utility and pitfalls—Comment on Russell‐Goldman Et Al.” Cancer Cytopathology (2019): n. pag. Print.
@article{8600771,
  author       = {Creytens, David},
  issn         = {1934-662X},
  journal      = {Cancer Cytopathology},
  publisher    = {Wiley},
  title        = {NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls---Comment on Russell\unmatched{2010}Goldman et al},
  url          = {http://dx.doi.org/10.1002/cncy.22108},
  year         = {2019},
}

Altmetric
View in Altmetric